Adriana C.
- Country
- Romania
- Department
- Rheumatology Department
Research Overview
- Efficacy and Safety Evaluation of Deucravacitinib in Biologic-Naïve Patients with Active Psoriatic Arthritis: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1)
Data & Insights
Has run more than one trial at 16 of 97 partner sites.
Specializations
Autoimmune Disorders
The investigator specializes in treating complex autoimmune conditions, with particular focus on Systemic Lupus Erythematosus (SLE). Their research encompasses innovative therapeutic approaches for managing active SLE manifestations.
- SLE Treatment Optimization
- Novel Therapeutic Approaches
- Disease Activity Management
Their work contributes to advancing treatment options for patients with challenging autoimmune presentations.
Rheumatological Conditions
The investigator conducts research in the field of inflammatory joint disorders, specifically focusing on Psoriatic Arthritis (PsA). Their expertise includes evaluation of treatment approaches for biologic-naive patients.
- Psoriatic Arthritis Management
- Treatment Response Assessment
- Early Intervention Strategies
Their research explores therapeutic solutions for patients with active psoriatic arthritis requiring targeted intervention.
Therapeutic Innovation
The investigator evaluates emerging treatments in rheumatology and immunology, with particular attention to novel therapeutic agents. Their work includes comparative assessments of new treatment modalities.
- Clinical Efficacy Assessment
- Treatment Safety Evaluation
- Therapeutic Response Monitoring
Their research contributes to the development of evidence-based treatment protocols for autoimmune conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.